期刊文献+

151例肝病患者经鼻电子胃镜的临床应用

Clinical Application of Ultrathin Electronic Gastroscopy in 151 Patients with Liver Diseases
暂未订购
导出
摘要 目的探讨各类肝脏疾病患者经鼻胃镜的临床应用价值。方法 151例肝脏疾病患者进行了经鼻胃镜检查,并注意贲门、十二指肠降部、胃底贲门反转及小标本活检的操作技巧。结果 151例肝病患者均完成上消化道检查,A级观察例数为144例,A级观察率为95.4%。结论经鼻胃镜可完成通用型电子胃镜的诊断功能,患者术前恐惧感小,术中不适感及术中术后并发症轻而少。 Objective To explore the usefulness and techniques of the clinical application of ultrathin transnasal gastroscope in patients with liver diseases.Methods 151 patients with liver diseases were examined using ultrathin transnasal gastroscope,with emphasis on the operating skills of cardia,descendant duodenum and the gastric fundus,as well as its application in the small biopsy specimen operation.Results Complete examination was made in all 151 cases.144 cases were reached A level observation,and the A level observation rate was 95.4%.Conclusion Transnasal gastroscope was capable of performing the diagnostic functions of the general purpose as well as transoral electronic gastroscope.Patients suffered low pre-operation distress,little inoperation discomforts and minor and slight in-operation and after-operation complications.
出处 《中国医药指南》 2012年第29期580-581,共2页 Guide of China Medicine
关键词 肝病 经鼻胃镜 耐受性 安全性 Liver diseases Transnasal gastroscope Tolerance Safty
  • 相关文献

参考文献5

二级参考文献16

  • 1LucioTrevisani,SergioSartori,PiergiorgioGaudenzi,GiuseppeGilli,GiancarloMatarese,SergioGullini,VincenzoAbbasciano.Upper gastrointestinal endoscopy:Are preparatory interventions or conscious sedation effective? A randomized trial[J].World Journal of Gastroenterology,2004,10(22):3313-3317. 被引量:4
  • 2王鸿利.血栓和血液检验[M].北京:北京科学出版社,1999.1321.
  • 3沈根荣 余书文.重症肝炎[M].天津:天津科学技术出版社,1998.53.
  • 4江忠仪 巫向前 王鸿利.乙型肝炎病毒纤溶活性标志物水平测定及其临床意义[J].实用医学检验杂志,1999,6(1):29-29.
  • 5[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
  • 6[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
  • 7[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
  • 8[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.
  • 9[7]Sehetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl, 1998, 66: 96-101.
  • 10[8]Okajima K. Clinical revelevance of determination of plasma AT Ⅲ and α2 antiplasmin activities in patients with DIC application of the molecularmarkers for the analysis of pathophysiology of DIC. Rinsho Byori,1994, 42 (1): 45-55.

共引文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部